CGeneTech Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
83
- Latest Deal Type
-
IPO
- Investors
-
18
CGeneTech General Information
Description
Owner and operator of a bio-pharmaceutical company intended to manufacture and sell synthetic DNA purification kits used for research and medicinal purposes. The company's services together with offshore sites, providing clients with a comprehensive portfolio of efficient and cost-effective chemistry systems for all stages of small molecule drug discovery, from initial hit generation, to hit-to-lead, to lead optimization, pre-clinical candidate identification, process research and scale-up, enabling pharmaceutical and biotech clients to increase their productivity by getting catalog products and custom synthesis services.
Contact Information
Website
www.cgenetech.com.cnCorporate Office
- 1st Floor, Building C11, Biomedical Industrial Park
- No. 218 Xinghu Street, Suzhou Industrial Park
- Suzhou, Jiangsu 215123
- China
Corporate Office
- 1st Floor, Building C11, Biomedical Industrial Park
- No. 218 Xinghu Street, Suzhou Industrial Park
- Suzhou, Jiangsu 215123
- China
CGeneTech Timeline
CGeneTech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. IPO | 25-Sep-2025 | Completed | Generating Revenue | |||
| 11. Secondary Transaction - Private | 12-Mar-2025 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series C) | 26-Aug-2024 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series B1) | 17-Mar-2023 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series B) | 05-Mar-2021 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | 07-Jan-2020 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A1) | 08-Oct-2019 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 28-Dec-2018 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 15-Dec-2017 | $10.6M | $13.5M | Completed | Generating Revenue | |
| 3. Later Stage VC | 13-Sep-2017 | $1.52M | $2.93M | Completed | Generating Revenue |
CGeneTech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 1,235,636 | $1.13 | $1.13 | 1x | $1.13 | 4.66% | ||
| Ordinary | 2,356,357 | $0.52 | $0.52 | 1x | $0.52 | 8.89% |
CGeneTech Patents
CGeneTech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4530288-A1 | Compound containing gem-difluoro group, preparation method therefor and use thereof | Pending | 05-Jul-2022 | ||
| EP-4530288-A4 | Compound containing gem-difluoro group, preparation method therefor and use thereof | Pending | 05-Jul-2022 | ||
| WO-2024007976-A1 | Compound containing gem-difluoro group, preparation method therefor and use thereof | Inactive | 05-Jul-2022 | ||
| US-20250136608-A1 | Compounds containing a gem-difluoride group and preparation method and use thereof | Pending | 05-Jul-2022 | ||
| EP-4446322-A1 | Cyclopropanamide-containing compound and use thereof | Pending | 18-Jan-2022 | C07D471/04 |
CGeneTech Signals
CGeneTech Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Nanjing Herun Investment | Growth/Expansion | Minority | ||
| Bosera Capital | Asset Manager | Minority | ||
| Jiarui Capital | Asset Manager | Minority | ||
| Prosperity & Vision | Asset Manager | Minority | ||
| Suzhou Asset Management | Asset Manager | Minority |
CGeneTech FAQs
-
When was CGeneTech founded?
CGeneTech was founded in 2010.
-
Where is CGeneTech headquartered?
CGeneTech is headquartered in Suzhou, China.
-
What is the size of CGeneTech?
CGeneTech has 83 total employees.
-
What industry is CGeneTech in?
CGeneTech’s primary industry is Drug Discovery.
-
Is CGeneTech a private or public company?
CGeneTech is a Private company.
-
What is CGeneTech’s current revenue?
The current revenue for CGeneTech is .
-
How much funding has CGeneTech raised over time?
CGeneTech has raised $94M.
-
Who are CGeneTech’s investors?
Nanjing Herun Investment, Bosera Capital, Jiarui Capital, Prosperity & Vision, and Suzhou Asset Management are 5 of 18 investors who have invested in CGeneTech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process